Navigation Links
Danaher Corporation Announces Retirement of Executive Vice President Philip W. Knisely
Date:7/27/2009

WASHINGTON, July 27 /PRNewswire-FirstCall/ -- Danaher Corporation (NYSE: DHR) announced today that Philip W. Knisely, Executive Vice President, has decided to retire from Danaher effective as of the end of 2009.

Mr. Knisely has served as an Executive Vice President since joining Danaher in 2000.

"Phil has made tremendous contributions to the growth and evolution of the Danaher portfolio over the past nine years," said H. Lawrence Culp, Jr., President and Chief Executive Officer. "We have benefited greatly from Phil's leadership and he will be missed."

Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies, and Tools and Components (www.danaher.com).

Statements in this release that are not strictly historical may be "forward-looking" statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These factors include, among other things, the risk factors described in our SEC filings, including our 2008 Annual Report on Form 10-K and Second Quarter 2009 Quarterly Report on Form 10-Q. These forward-looking statements speak only as of the date of this release and the Company does not assume any obligation to update any forward-looking statement.


'/>"/>
SOURCE Danaher Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Danaher Closes Subsequent Offering Period for Tektronix; Acquires Over 90% of TEK Shares
2. Danaher to Present at Citigroup Global Industrial Manufacturing Conference
3. Danaher Corporation Schedules First Quarter Conference Call
4. Danaher to Present at Goldman Sachs Global Industrials Conference
5. Danaher CEO Comments on Outlook
6. Danaher to Present at Barclays Capital Industrial Select Conference
7. Shareholders Challenge Danaher/Kerr to Phase Out Mercury Tooth Fillings
8. Danaher Announces Quarterly Dividend
9. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
10. Brooke Franchise Corporation Announces Selected July Results
11. MedThink Communications Retained by NanoBio Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Circadiance Launches NEW Zzzephyr Seal 28TM 29 for Its SleepWeaver 28TM 29 ADVANCE Mask Now Available in Three Colors 60056 1Circadiance Launches NEW Zzzephyr Seal 28TM 29 for Its SleepWeaver 28TM 29 ADVANCE Mask Now Available in Three Colors 60056 2STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 1STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 2STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 3STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 4STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 5STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 6Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 1Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 2Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 3